๐Ÿ‡ฎ๐Ÿ‡ชIreland
16ยฐC Partly Cloudy ยท Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide โ—† The โ‚ฌ100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany โ—† Ireland's โ‚ฌ93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact โ—† The Pharmacist's Role: How Community Pharmacies in Ireland and the UK Are Adapting as Patients Bypass High-Street Stores for Direct Delivery โ—† GLP-1 Therapeutics and Clinical Research Updates: Brain Reward Mapping, Oral Small Molecules, and Triple-Agonist Horizons โ—† Rinn Pharma & Biopharma Joins NordicPharmaTrain Network to Accelerate European Research & Advanced Manufacturing โ—† Markets Surge as August Opens: $400B Big Pharma Merger Speculation & AstraZeneca Deal Talks Grab Global Headlines โ—† Trumpโ€™s September Visit to Ireland: Agenda, Economic Policy Evaluation & U.S.-Irish Trade Implications โ—† Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide โ—† The โ‚ฌ100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany โ—† Ireland's โ‚ฌ93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact โ—† The Pharmacist's Role: How Community Pharmacies in Ireland and the UK Are Adapting as Patients Bypass High-Street Stores for Direct Delivery โ—† GLP-1 Therapeutics and Clinical Research Updates: Brain Reward Mapping, Oral Small Molecules, and Triple-Agonist Horizons โ—† Rinn Pharma & Biopharma Joins NordicPharmaTrain Network to Accelerate European Research & Advanced Manufacturing โ—† Markets Surge as August Opens: $400B Big Pharma Merger Speculation & AstraZeneca Deal Talks Grab Global Headlines โ—† Trumpโ€™s September Visit to Ireland: Agenda, Economic Policy Evaluation & U.S.-Irish Trade Implications โ—†
Updated 04 Jul 2026 ยท HPRA open data

Trastuzumab - Medicines in Ireland

19 authorised products containing Trastuzumab, from the HPRA register.

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0โ€“9
Showing 19 authorised medicines
MedicineActive substanceLicence holderStatus
Dazublys 150 mg powder for concentrate for solution for infusion
EU/1/25/1949/001
Trastuzumab Curateq Biologics s.r.o. โ€”
Herceptin 150 mg powder for concentrate for solution for infusion
EU/1/00/145/001
Trastuzumab Roche Registration GmbH โ€”
Herceptin 600 mg solution for injection in vial
EU/1/00/145/002
Trastuzumab Roche Registration GmbH โ€”
Herwenda 150 mg powder for concentrate for solution for infusion
EU/1/23/1762/001
Trastuzumab Sandoz GmbH โ€”
Herzuma 150 mg powder for concentrate for solution for infusion
EU/1/17/1257/001
Trastuzumab Celltrion Healthcare Hungary Kft. โ€”
Herzuma 420 mg powder for concentrate for solution for infusion
EU/1/17/1257/002-003
Trastuzumab Celltrion Healthcare Hungary Kft. โ€”
KANJINTI 150 mg powder for concentrate for solution for infusion
EU/1/18/1281/001
Trastuzumab Amgen Europe B.V. โ€”
KANJINTI 420 mg powder for concentrate for solution for infusion
EU/1/18/1281/002
Trastuzumab Amgen Europe B.V. โ€”
Ogivri 150 mg powder for concentrate for solution for infusion
EU/1/18/1341/001
Trastuzumab Biosimilar Collaborations Ireland Limited โ€”
Ogivri 420 mg powder for concentrate for solution for infusion
EU/1/18/1341/002
Trastuzumab Biosimilar Collaborations Ireland Limited โ€”
Ontruzant 150 mg Powder for concentrate for solution for infusion
EU/1/17/1241/001
Trastuzumab Samsung Bioepis NL B.V. โ€”
Phesgo 1200 mg/600 mg solution for injection
EU/1/20/1497/001
Pertuzumab, Trastuzumab Roche Registration GmbH โ€”
Phesgo 600 mg/600 mg solution for injection
EU/1/20/1497/002
Pertuzumab, Trastuzumab Roche Registration GmbH โ€”
Trazimera 150 mg powder for concentrate for solution for infusion
EU/1/18/1295/001
Trastuzumab Pfizer Europe MA EEIG โ€”
Tuznue 150 mg Powder for concentrate for solution for infusion
EU/1/24/1864/001
Trastuzumab Prestige Biopharma Belgium โ€”
Tuznue 420 mg Powder for concentrate for solution for infusion
EU/1/24/1864/002
Trastuzumab Prestige Biopharma Belgium โ€”
Zercepac 150 mg Powder for concentrate for solution for infusion
EU/1/20/1456/001
Trastuzumab Accord Healthcare S.L.U. โ€”
Zercepac 420 mg powder for concentrate for solution for infusion
EU/1/20/1456/003
Trastuzumab Accord Healthcare S.L.U. โ€”
Zercepac 60 mg powder for concentrate for solution for infusion
EU/1/20/1456/002
Trastuzumab Accord Healthcare S.L.U. โ€”
Cite this database

Priya Life Science (2026). Irish Medicines Database. Available at: https://priyalifescience.com/medicines (Accessed: 13 August 2026).

Data: Health Products Regulatory Authority (HPRA) open dataset (โ€œAuthorised or Transfer Pending Productsโ€), licensed CC BY 4.0, refreshed daily. Regulatory information only โ€” not medical advice.